ICR and Merck renew strategic alliance in discovery and development of innovative new small-molecule cancer drugs 22 Sep 2023 The Institute of Cancer Research, London, and science and technology company Merck have renewed their strategic alliance in the discovery and development of new cancer drugs. Find out more Show/Hide
Immuno-oncology collaboration to develop innovative new type of cancer drug 18 Apr 2023 Scientists at The Institute of Cancer Research, London, are teaming up with small molecule neoantigen immuno-oncology company NeoPhore to develop new potential cancer drugs. Find out more Show/Hide
ICR’s in-person business partnering events return! 25 Jul 2022 Our Partnering to Defeat Cancer series of business networking events returned this month, with scientists from The Institute of Cancer Research giving presentations on their work to an audience of industry professionals before a networking reception. Find out more Show/Hide
New drug for difficult-to-drug cancer mutation could be key treatment for a range of cancers 29 Oct 2020